UBS Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $138M | Buy |
2,843,577
+771,685
| +37% | +$37.5M | 0.02% | 608 |
|
|
2025
Q1 | $70.5M | Buy |
2,071,892
+87,902
| +4% | +$2.99M | 0.01% | 936 |
|
|
2024
Q4 | $78.1M | Buy |
1,983,990
+1,310,402
| +195% | +$51.6M | 0.01% | 834 |
|
|
2024
Q3 | $31.6M | Buy |
673,588
+249,372
| +59% | +$11.7M | 0.01% | 1041 |
|
|
2024
Q2 | $22.9M | Buy |
424,216
+103,839
| +32% | +$5.61M | 0.01% | 1151 |
|
|
2024
Q1 | $21.8M | Buy |
320,377
+9,472
| +3% | +$646K | 0.01% | 1152 |
|
|
2023
Q4 | $19.5M | Sell |
310,905
-26,225
| -8% | -$1.64M | 0.01% | 1107 |
|
|
2023
Q3 | $15.3M | Buy |
337,130
+74,470
| +28% | +$3.38M | 0.01% | 1179 |
|
|
2023
Q2 | $14.7M | Buy |
262,660
+17,807
| +7% | +$1,000K | 0.01% | 1220 |
|
|
2023
Q1 | $11.1M | Sell |
244,853
-203,682
| -45% | -$9.21M | ﹤0.01% | 1308 |
|
|
2022
Q4 | $18.2M | Buy |
448,535
+180,573
| +67% | +$7.34M | 0.01% | 1047 |
|
|
2022
Q3 | $17.5M | Buy |
267,962
+34,043
| +15% | +$2.22M | 0.01% | 990 |
|
|
2022
Q2 | $14.2M | Buy |
233,919
+30,487
| +15% | +$1.85M | 0.01% | 1156 |
|
|
2022
Q1 | $12.8M | Buy |
203,432
+13,542
| +7% | +$850K | ﹤0.01% | 1303 |
|
|
2021
Q4 | $14.4M | Buy |
189,890
+50,237
| +36% | +$3.81M | ﹤0.01% | 1302 |
|
|
2021
Q3 | $15.6M | Buy |
139,653
+23,879
| +21% | +$2.67M | ﹤0.01% | 1258 |
|
|
2021
Q2 | $18.7M | Sell |
115,774
-122,105
| -51% | -$19.8M | 0.01% | 1143 |
|
|
2021
Q1 | $29M | Buy |
237,879
+102,618
| +76% | +$12.5M | 0.01% | 867 |
|
|
2020
Q4 | $20.7M | Buy |
135,261
+42,068
| +45% | +$6.44M | 0.01% | 998 |
|
|
2020
Q3 | $7.8M | Buy |
93,193
+8,799
| +10% | +$736K | ﹤0.01% | 1430 |
|
|
2020
Q2 | $6.2M | Buy |
84,394
+15,848
| +23% | +$1.16M | ﹤0.01% | 1473 |
|
|
2020
Q1 | $2.91M | Buy |
68,546
+12,153
| +22% | +$515K | ﹤0.01% | 1879 |
|
|
2019
Q4 | $3.44M | Buy |
56,393
+10,936
| +24% | +$666K | ﹤0.01% | 2301 |
|
|
2019
Q3 | $1.86M | Sell |
45,457
-11,507
| -20% | -$472K | ﹤0.01% | 2663 |
|
|
2019
Q2 | $2.68M | Buy |
56,964
+570
| +1% | +$26.8K | ﹤0.01% | 2291 |
|
|
2019
Q1 | $2.02M | Buy |
56,394
+5,400
| +11% | +$193K | ﹤0.01% | 2425 |
|
|
2018
Q4 | $1.46M | Sell |
50,994
-30,560
| -37% | -$873K | ﹤0.01% | 2700 |
|
|
2018
Q3 | $3.62M | Sell |
81,554
-971
| -1% | -$43.1K | ﹤0.01% | 2142 |
|
|
2018
Q2 | $4.85M | Buy |
82,525
+23,130
| +39% | +$1.36M | ﹤0.01% | 1886 |
|
|
2018
Q1 | $2.72M | Buy |
59,395
+57,025
| +2,406% | +$2.61M | ﹤0.01% | 2322 |
|
|
2017
Q4 | $56K | Buy |
2,370
+1,800
| +316% | +$42.5K | ﹤0.01% | 4801 |
|
|
2017
Q3 | $10K | Sell |
570
-958
| -63% | -$16.8K | ﹤0.01% | 5968 |
|
|
2017
Q2 | $25K | Buy |
1,528
+958
| +168% | +$15.7K | ﹤0.01% | 5199 |
|
|
2017
Q1 | $12K | Sell |
570
-3,472
| -86% | -$73.1K | ﹤0.01% | 5576 |
|
|
2016
Q4 | $82K | Buy |
+4,042
| New | +$82K | ﹤0.01% | 4541 |
|